
How to Identify and Treat Hypomagnesemia - Medscape
May 15, 2025 · Although most patients with hypomagnesemia are asymptomatic, severe magnesium deficiency can be fatal.
Ask the Experts - Hypomagnesemia - Medscape
Apr 19, 2001 · My question concerns hypomagnesemia. The patient is a 66-year-old well-nourished white female with polymyalgia rheumatica who was taking prednisone for this condition. She …
Better Outcomes With Antithrombotics: Here’s How PPIs Help
Feb 11, 2025 · Another side effect of PPIs is hypomagnesemia, as PPIs inhibit magnesium absorption, especially in patients aged more than 65 years.
Magnesium and Metabolic Syndrome: Any Connection? - Medscape
Mar 21, 2024 · Magnesium deficiency was linked to an increased risk for metabolic syndrome proportional to the severity of the deficiency.
Long-Term PPI Use Associated With Low Magnesium - Medscape
Mar 2, 2011 · Because hypomagnesemia is likely to be underrecognized and underreported, however, available data were insufficient to quantify an incidence rate for hypomagnesemia associated with …
Study: Screening Prevents Alcohol Withdrawal Post-Surgery
Sep 9, 2025 · For example, you can see hypokalemia (low potassium), hypomagnesemia (low magnesium), hyponatremia (low sodium levels), and even low phosphorus levels, said Pawlik.
PPI Use and the Risk of Pseudogout - Medscape
Mar 16, 2022 · The incident use of both proton pump inhibitors (PPIs) and H2 blockers, either alone or in combination, was associated with a higher risk of calcium pyrophosphate crystal deposition (CPPD ...
Back Pain or Breast Cancer? A 60-Year-Old Man’s Case - Medscape
Sep 3, 2025 · A 60-year-old man with back pain presented with advanced breast cancer after years of delayed follow-up.
Why Does Hypokalemia Happen With Amphotericin B? - Medscape
May 27, 2014 · Why does amphotericin B cause hypokalemia, and how can it be managed? Once patients begin to develop hypokalemia following AmB administration, maintaining adequate …
Exceptional Use Recommendation for Nuclear Emergency Drug
Jun 20, 2025 · The EMA has given a positive opinion for the exceptional circumstances authorization of Imreplys (sargramostim) to treat myelosuppression after acute radiation exposure.